Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -3.73% and Operating profit at -32.85% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 1,613.44% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -3.73% and Operating profit at -32.85% over the last 5 years
3
The company has declared Negative results for the last 6 consecutive quarters
Stock DNA
Pharmaceuticals & Biotechnology
CNY 737 Million (Micro Cap)
26.00
NA
0.69%
-0.53
3.74%
0.98
Revenue and Profits:
Net Sales:
112 Million
(Quarterly Results - Jun 2025)
Net Profit:
5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
38.67%
0%
38.67%
6 Months
34.96%
0%
34.96%
1 Year
82.25%
0%
82.25%
2 Years
34.58%
0%
34.58%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.73%
EBIT Growth (5y)
-32.85%
EBIT to Interest (avg)
52.47
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.68
Tax Ratio
13.36%
Dividend Payout Ratio
51.04%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1,992.57%
ROE (avg)
1,613.44%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
0.98
EV to EBIT
14.52
EV to EBITDA
5.42
EV to Capital Employed
0.96
EV to Sales
0.71
PEG Ratio
NA
Dividend Yield
0.69%
ROCE (Latest)
6.58%
ROE (Latest)
3.74%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
112.00
121.40
-7.74%
Operating Profit (PBDIT) excl Other Income
13.90
17.50
-20.57%
Interest
0.00
0.00
Exceptional Items
0.50
-0.00
Consolidate Net Profit
4.90
11.90
-58.82%
Operating Profit Margin (Excl OI)
35.90%
65.50%
-2.96%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -7.74% vs -23.55% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -58.82% vs -48.71% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
474.10
531.00
-10.72%
Operating Profit (PBDIT) excl Other Income
69.10
86.60
-20.21%
Interest
0.50
0.60
-16.67%
Exceptional Items
0.90
-1.30
169.23%
Consolidate Net Profit
40.00
60.30
-33.67%
Operating Profit Margin (Excl OI)
63.90%
105.00%
-4.11%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -10.72% vs -2.44% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -33.67% vs -14.95% in Dec 2023
About Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. 
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






